Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Hoth Therapeutics Inc (HOTH)

Hoth Therapeutics Inc (HOTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,393
  • Shares Outstanding, K 23,974
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,200 K
  • 60-Month Beta 1.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.45
Trade HOTH with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.52
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/15/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.16
  • Number of Estimates 1
  • High Estimate -0.16
  • Low Estimate -0.16
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6350 +19.51%
on 12/29/21
1.7500 -56.63%
on 01/04/22
+0.0188 (+2.54%)
since 12/17/21
3-Month
0.6350 +19.51%
on 12/29/21
1.7500 -56.63%
on 01/04/22
-0.3711 (-32.84%)
since 10/19/21
52-Week
0.6350 +19.51%
on 12/29/21
3.5000 -78.32%
on 02/18/21
-1.3911 (-64.70%)
since 01/19/21

Most Recent Stories

More News
Global Alzheimer’s Disease Therapeutics Market Projected To Generate Revenue Of $9.97 Billion By 2028

Palm Beach, FL –January 4, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease is a degenerative, progressive ailment that attacks the brain’s nerve cells, resulting in memory...

HOTH : 0.7504 (+3.43%)
ABBV : 136.33 (-0.33%)
SNY : 52.05 (-0.23%)
REGN : 620.19 (+1.47%)
SAVA : 40.25 (-2.97%)
Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options

Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to...

HOTH : 0.7504 (+3.43%)
AMGN : 233.09 (-0.32%)
LGVN : 7.98 (-4.89%)
BMY : 65.24 (+0.54%)
TAK : 14.43 (-0.82%)
Systemic Lupus Erythematosus Treatment Market Projected To Reach $3.56 Billion By 2027

Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The...

HOTH : 0.7504 (+3.43%)
ABBV : 136.33 (-0.33%)
LGVN : 7.98 (-4.89%)
PETV : 2.79 (+4.10%)
AMGN : 233.09 (-0.32%)
Increased Prevalence of Atopic Dermatitis Fueling Impressive Growth for Atopic Dermatitis Drugs

Palm Beach, FL –November 30, 2021 – FinancialNewsMedia.com News Commentary – Atopic dermatitis is a chronic inflammatory skin condition characterized by red, itchy, swollen, and broken skin. White...

HOTH : 0.7504 (+3.43%)
LGVN : 7.98 (-4.89%)
REGN : 620.19 (+1.47%)
SNY : 52.05 (-0.23%)
NVS : 88.87 (-0.75%)
Global Cancer Therapy Market Expected to Reach $268 Billion In 2026, With A CAGR Of 9.15%

Palm Beach, FL –November 16, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy...

HOTH : 0.7504 (+3.43%)
SAVA : 40.25 (-2.97%)
CEI : 0.6450 (-9.15%)
BIIB : 232.59 (-0.52%)
ICPT : 17.25 (+4.17%)
Hoth Therapeutics Extends Partnership Agreement with REPROCELL

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) has extended its partnership agreement with REPROCELL to assess the effect of the HT-003 therapeutic...

HOTH : 0.7504 (+3.43%)
Global Atopic Dermatitis Treatment Market Size Is Projected To Be Worth US$21.80 Billion By 2026

Palm Beach, FL –October 12, 2021 – FinancialNewsMedia.com News Commentary – Atopic Dermatitis is an inflammatory skin disease, and the degree of its severity varies from patient to patient. It usually...

HOTH : 0.7504 (+3.43%)
SAVA : 40.25 (-2.97%)
BIIB : 232.59 (-0.52%)
CEI : 0.6450 (-9.15%)
ICPT : 17.25 (+4.17%)
Global Atopic Dermatitis Treatment Market Size Is Projected To Be Worth US$21.80 Billion By 2026

/PRNewswire/ -- Atopic Dermatitis is an inflammatory skin disease, and the degree of its severity varies from patient to patient. It usually begins in...

HOTH : 0.7504 (+3.43%)
SAVA : 40.25 (-2.97%)
BIIB : 232.59 (-0.52%)
CEI : 0.6450 (-9.15%)
ICPT : 17.25 (+4.17%)
Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York Times

“The Vaccines We Have Are Good. But They Could Be So Much Better”

HOTH : 0.7504 (+3.43%)
Voltron Therapeutics, Inc. Announces COVID-19 and Pandemic Preparedness Presentation to Congressional Offices and Agencies, Including HHS, NIH, FDA, and DoD

NEW YORK, April 13, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc.  today announced that the Company presented to Congressional Offices and Agencies, including HHS, NIH, FDA and the DoD on Thursday...

HOTH : 0.7504 (+3.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Hoth Therapeutics Inc. is a development stage biopharmaceutical company. It focused on therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. The company's BioLexa(TM) Platform is a proprietary, patented drug compound platform. Hoth Therapeutics Inc. is...

See More

Key Turning Points

3rd Resistance Point 0.8737
2nd Resistance Point 0.8418
1st Resistance Point 0.7837
Last Price 0.7504
1st Support Level 0.6937
2nd Support Level 0.6618
3rd Support Level 0.6037

See More

52-Week High 3.5000
Fibonacci 61.8% 2.4056
Fibonacci 50% 2.0675
Fibonacci 38.2% 1.7294
Last Price 0.7504
52-Week Low 0.6350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar